EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

EBUS‐TBNA for mediastinal staging of centrally located T1N0M0 non‐small cell lung cancer clinically staged with PET/CT

Pere Serra Mitjà iD, Bruno García-Cabo, Ignasi Garcia-Olivé iD, Joaquim Radua, Ramón Rami-Porta, Lluís Esteban, Bienvenido Barreiro, Sergi Call, Carmen Centeno, Felipe Andreo, Carme Obiols, Juan Manuel Ochoa und 4 weitere

Respirology · 2024

DOI: 10.1111/resp.14613 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Respirology, 2024. Verfasst von Pere Serra Mitjà und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective To evaluate the diagnostic accuracy and clinical usefulness of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for mediastinal staging of centrally located T1N0M0 non‐small cell lung cancer (NSCLC) clinically staged with positron emission tomography/computed tomography (PET/CT).

Methods

We conducted a study that included patients with centrally located T1N0M0 NSCLC, clinically staged with PET/CT who underwent EBUS‐TBNA for mediastinal staging. Patients with negative EBUS‐TBNA underwent mediastinoscopy, video‐assisted mediastinoscopic lymphadenectomy (VAMLA) and/or lung resection with systematic nodal dissection, that were considered the gold standard. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), overall accuracy of EBUS‐TBNA for diagnosing mediastinal metastases (N2 disease) and the number needed to treat (NNT: number of patients needed to undergo EBUS‐TBNA to avoid a case of pathologic N2 disease after resection) were calculated.

Results

One‐hundred eighteen patients were included. EBUS‐TBNA proved N2 disease in four patients. In the remaining 114 patients who underwent mediastinoscopy, VAMLA and/or resection there were two cases of N2 (N2 prevalence 5.1%). The sensitivity, specificity, NPV, PPV and overall accuracy for diagnosing mediastinal metastases (N2 disease) were of 66%, 100%, 98%, 100% and 98%, respectively. The NNT was 31 (95% CI: 15–119).

Conclusion

EBUS‐TBNA in patients with central clinically staged T1N0M0 NSCLC presents a good diagnostic accuracy for mediastinal staging, even in a population with low prevalence of N2 disease. Therefore, its indication should be considered in the management of even these early lung cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansPositron Emission Tomography Computed TomographyMediastinumEndoscopic Ultrasound-Guided Fine Needle AspirationNeoplasm StagingLymph NodesRetrospective StudiesEndosonography

Stichwörter der Autor:innen

EBUS-TBNANSCLCcT1N0endobronchial ultrasound-guided transbronchial needle aspirationmediastinumnon-small cell lung cancerstaging

Autor:innen und Institutionen

  • Pulmonology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
  • Pulmonology Department, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain.
  • Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Catalonia, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, University of Barcelona, Barcelona, Spain.
  • Thoracic Surgery Department, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain.
  • Network of Centres for Biomedical Research on Respiratory Diseases (CIBERES), Lung Cancer Group, Terrassa, Barcelona, Spain.

ORCID-Profile: Pere Serra Mitjà, Ignasi Garcia-Olivé, José Sanz-Santos

Zitieren

APA

Serra Mitjà, P., García-Cabo, B., Garcia-Olivé, I., Radua, J., Rami-Porta, R., Esteban, L., Barreiro, B., Call, S., Centeno, C., Andreo, F., Obiols, C., Ochoa, J. M., Martínez-Palau, M., Reig, N., Serra, M., & Sanz-Santos, J. (2024). EBUS‐TBNA for mediastinal staging of centrally located T1N0M0 non‐small cell lung cancer clinically staged with PET/CT. Respirology. https://doi.org/10.1111/resp.14613

Vancouver

Serra Mitjà P, García-Cabo B, Garcia-Olivé I, Radua J, Rami-Porta R, Esteban L, et al. EBUS‐TBNA for mediastinal staging of centrally located T1N0M0 non‐small cell lung cancer clinically staged with PET/CT. Respirology. 2024. doi:10.1111/resp.14613

BibTeX
@article{SerraMitj2024,
  author = {Serra Mitjà, Pere and García-Cabo, Bruno and Garcia-Olivé, Ignasi and Radua, Joaquim and Rami-Porta, Ramón and Esteban, Lluís and Barreiro, Bienvenido and Call, Sergi and Centeno, Carmen and Andreo, Felipe and Obiols, Carme and Ochoa, Juan Manuel and Martínez-Palau, Mireia and Reig, Nina and Serra, Mireia and Sanz-Santos, José},
  title = {EBUS‐TBNA for mediastinal staging of centrally located T1N0M0 non‐small cell lung cancer clinically staged with PET/CT},
  journal = {Respirology},
  year = {2024},
  doi = {10.1111/resp.14613}
}
Kostenlos starten →